Although Denso is no longer in a net cash position, in fiscal 2023 net debt/EBITDA remained low at 0.2. Since 2012, the company has been able to self-fund its investments through its cash flow from ...
A fuel cell is a device that generates electric energy through electrochemical reactions between an oxidizing agent and a fuel – a material that stores energy in chemical form. Both species are ...
The Duramax diesel is a series of diesel engines manufactured by General Motors. Here's a breakdown of the generations over ...
Not only will a good filter remove impurities, it'll also improve the taste and clarity of water. And compared with buying bottled water, using a water filter pitcher is substantially more ...
Fuel economy is one of the most important factors to consider when buying a new car because it has an impact on your weekly operating costs. In fact, Americans are more likely to name fuel economy ...
Lenses are precious, fragile, and often expensive – and if something has to get cracked against the ground, wouldn't you rather it was a $20 filter than the front element of a $1,000 lens? Protective ...
Wonder Land: The debacle of President Biden's final year in office was his conscious choice. Photo: Will Oliver - Pool via CNP/Zuma Press Nippon Steel and U.S. Steel last week filed a lawsuit ...
Nippon Steel Corp. said Tuesday it "remains the only partner" for United States Steel Corp., vowing to continue pursuing its purchase despite White House opposition and the emergence of a rival offer ...
Lourenco Goncalves, Cleveland-Cliffs’ chairman, president, and CEO. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance ...
Copyright 2025 The Associated Press. All Rights Reserved. A person walks past a Nippon Steel Corporation sign at the company headquarters Tuesday, Jan. 7, 2025, in ...
Lourenco Goncalves, CEO of Cleveland-Cliffs, called Japan, the home of rival steelmaker Nippon Steel, ”evil” in a press conference on Monday, as the U.S. company prepares a new bid for U.S ...
In exchange for its investigational gene therapies, Regenxbio will receive $110 million upfront and up to $700 million in milestones. After hitting an all-time low of $6.95 at close of business ...